Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study

Nathania A.J.B. Cooksley, David Atkinson, Guy B. Marks, Brett G. Toelle, David Reeve, David P. Johns, Michael J. Abramson, Deborah L. Burton, Alan L. James, Richard Wood-Baker, E. Haydn Walters, A. Sonia Buist, Graeme P. Maguire

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Background and objective Mortality and hospital separation data suggest a higher burden of chronic obstructive pulmonary disease (COPD) in indigenous than non-indigenous subpopulations of high-income countries. This study sought to accurately measure the true prevalence of post-bronchodilator airflow obstruction and forced vital capacity reduction in representative samples of Indigenous and non-Indigenous Australians. Methods This study applies cross-sectional population-based survey of Aboriginal and non-Indigenous residents of the Kimberley region of Western Australia aged 40 years or older, following the international Burden Of Lung Disease (BOLD) protocol. Quality-controlled spirometry was conducted before and after bronchodilator. COPD was defined as Global initiative for chronic Obstructive Lung Disease (GOLD) Stage 2 and above (post-bronchodilator forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) ratio <0.7 and FEV1-<-80% predicted). Results Complete data were available for 704 participants. The prevalence of COPD, adjusted for age, gender and body weight in Aboriginal participants (7.2%, 95% confidence interval (CI) 3.9 to 10.4) was similar to that seen in non-Indigenous Kimberley participants (8.2%, 95% CI 5.7 to 10.7) and non-Indigenous residents of the remainder of Australia (7.1%, 95% CI 6.1 to 8.0). The prevalence of low FVC (<80% predicted) was substantially higher in Aboriginal compared with non-Indigenous participants (74.0%, 95% CI 69.1 to 78.8, vs 9.7%, 95% CI 7.1 to 12.4). Conclusions Low FVC, rather than airflow obstruction, characterizes the impact of chronic lung disease previously attributed to COPD in this population subject to significant social and economic disadvantage. Environmental risk factors other than smoking as well as developmental factors must be considered. These findings require further investigation and have implications for future prevention of chronic lung disease in similar populations. In Aboriginal Australians and similar populations subject to significant social and environmental disadvantage, differences in FVC may be so great that they translate to a clinically relevant reduction in baseline respiratory reserve. Low FVC may therefore characterize the impact of chronic lung disease previously attributed to COPD in Aboriginal Australians. See Editorial, page 693

Original languageEnglish (US)
Pages (from-to)766-774
Number of pages9
JournalRespirology
Volume20
Issue number5
DOIs
StatePublished - Jul 1 2015

Keywords

  • chronic obstructive pulmonary disease
  • indigenous population
  • race
  • respiratory function test
  • vital capacity

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study'. Together they form a unique fingerprint.

  • Cite this

    Cooksley, N. A. J. B., Atkinson, D., Marks, G. B., Toelle, B. G., Reeve, D., Johns, D. P., Abramson, M. J., Burton, D. L., James, A. L., Wood-Baker, R., Walters, E. H., Buist, A. S., & Maguire, G. P. (2015). Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study. Respirology, 20(5), 766-774. https://doi.org/10.1111/resp.12482